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Abstract
There are few reported cases of cavernous transformation of the 
portal vein (CTPV) in adults.  We present a case of a 58 year-old 
male who was found to have this complication due to portal vein 
thrombosis (PVT). A 58-year old African American male with 
chronic alcohol and tobacco use presented with a 25-day history 
of weakness, generalized malaise, nausea and vomiting associated 
with progressively worsening anorexia and weight loss. The patient 
was admitted for severe anemia in conjunction with abnormal liver 
function tests and electrolyte abnormalities, and to rule out end 
stage liver disease or hepatic malignancy. The work-up for anemia 
showed no significant colon abnormalities, cholecystitis, liver cir-
rhosis, or liver abnormalities but could not rule out malignancy. An 
esophageogastroduodenoscopy (EGD) was suspicious for a mass 
compressing the stomach and small bowel. After further work-up, 
the hepatic mass has been diagnosed as a cavernous transformation 
of the portal vein (CTPV), a very rare complication of portal vein 
thrombosis (PVT). Cavernous Transformation of the Portal Vein 
(CTPV) is a rare and incurable complication of portal vein throm-
bosis (PVT) that should be considered as one of the differential 
diagnoses of a hepatic mass.
Keywords: Cavernous transformation of the portal vein; Portal 
vein thrombosis; Portal hypertension; Hyperbilirubinemia; Hepatic 
mass
Introduction
Cavernous Transformation of the Portal Vein (CTPV) is a 
rare condition with various etiologies and diverse clinical 
presentations [1]. It occurs with long-standing portal vein 
thrombosis (PVT) which causes portal hypertension and 
an occlusion of the portal vein leading to the development 
and dilatation of multiple small vessels in and around the 
re-canalizing main portal vein [2, 3]. It has been found to 
occur commonly in patients with healthy livers with chronic 
non-cirrhotic and non-tumoral PVT. Yet, the causes of CTPV 
are unknown [4]. The main clinical presentations are gas-
troesophageal variceal bleeding and hematologic abnormali-
ties due to the effects of the collateral vessels resulting in 
an enlarged spleen and the development of porto-systemic 
collaterals. However, the diagnosis of CTPV is very rarely 
made on an adult with signs and symptoms of obstructive 
jaundice. Abdominal ultrasonography, color Doppler ultra-
sonography, computated tomography angiography (CTA), 
and magnetic resonance imaging (MRI) are used to confirm 
its diagnosis. We report a case of a male adult in whom the 
diagnosis of CTPV was made during the initial workup for a 
hepatic mass. The symptoms that led us to this rare diagnosis 
were hyperbilirubinemia and an extrinsic mass compress-
ing on the stomach and the small bowel without any signs 
of portal hypertension. Although the patient presented with 
anemia, no sources of bleeding were found, including the 
presence of esophageal varices.
Case Report
A 58-year-old African American male with a history of 
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chronic alcohol (a quart of distilled liquor a day for 40 years) 
and tobacco use (60 pack/years) was brought to the Emer-
gency Department of Woodhull Medical Center by his broth-
er due to progressively worsening fatigue, loss of appetite 
and a significant weight loss of 40 lb over the last 3 weeks. 
As per the patient, these symptoms started after his last alco-
hol consumption 3 weeks ago which was followed by nausea 
and multiple episodes of vomiting. The vomit was described 
as clear, with no presence of blood or bile. He denied of any 
fever, chills, night sweats, hemoptysis, shortness of breath, 
dizziness or pain. Patient was in mild distress appearing ill. 
He was alert and oriented to person, place and time. 
Vital signs were: blood pressure: 91/50 mmHg, heart 
rate: 106 beats/minute, respiration rate: 16 breaths/min, tem-
perature: 98.5 ºF, and oxygen saturation: 98% with 2 L nasal 
cannula.
Physical exam was remarkable for jaundiced sclerae. 
Abdomen was distended with increased bowel sounds, posi-
tive shifting dullness and no tenderness. A healed surgical 
scar was seen on the medial aspect of the abdomen which 
was consistent with a history of exploratory laparotomy 9 
years ago that the patient could not recall the reason for. 
Liver was palpated 2 cm under right costal border and spleen 
was not palpable. Upon rectal exam, guaiac positive stool 
was demonstrated.  Patient had fine intention tremors on 
both hands. 
Laboratory workup showed a marked hypokalemia (1.9 
mEq/ml) with magnesium of 1.1 mEq/ml. Calcium was 7.3 
mg/dL, but when corrected to albumin, its level was 8.4 
mEq/ml. Patient was anemic with the results of hemoglobin 
7.0 g/dl and hematocrit 22.5% with a MCV of 118 fL. Co-
agulation profile showed normal platelets with prothrombin 
time (PT) of 16.2 sec with INR of 1.94 and activated partial 
thromboplastin time (aPTT) of 41.4 sec. Liver profile result-
ed in AST: 87 U/L, ALT: 25 U/L, total bilirubin: 14 mg/dL. 
An arterial blood gas performed at FiO2 of 28% showed: pH: 
7.53, PCO2: 38.7 mmHg, PO2: 115 mmHg, O2 saturation: 
99%, bicarbonate: 32 mEq/L.Urinalysis was consistent with 
urinary tract infection with positive leukocytes. Chest X-ray 
and EKG were unremarkable.
Patient was admitted for severe symptomatic anemia, 
electrolyte imbalance, and to further investigate the abnor-
mal liver profile, and to treat urinary tract infection.
After the electrolyte abnormalities were corrected, pa-
tient had abdominal ultrasound and CT scan of abdomen and 
pelvis with oral contrast. The ultrasound showed gallbladder 
wall and diffuse circumferential large bowel wall thicken-
ing, and a moderate amount ascites which were consistent 
with cholecystitis and infectious enteritis. Cholecystigraphy 
(HIDA scan) reported no visualization of gallbladder indi-
cating cystic duct obstruction. Ultrasound with doppler did 
not show any thrombosis in the infrahepatic area of the por-
tal vein. CT scan of the abdomen and pelvis showed hepatic 
steatosis, multiple small tortuous vessels in the region of the 
porta hepatis and variceal veins along common bile duct. 
On the second day of admission, the patient developed 
watery, non-bloody, non-mucous diarrhea.  Colonoscopy 
found a single multi-nodular broad-based polyp in the ce-
cum, moderately congested mucosa in the entire colon, and 
moderately severe loss of haustral folds in the entire colon. 
Esophagogastroduodenoscopy (EGD) showed no varices but 
a moderately severe extrinsic impression was found in the 
antrum of the stomach and in duodenum. It also showed food 
in the body of the stomach and a small hiatal hernia. The 
mucosa was edematous, but there was no abnormal mucosal 
lesion. 
These results were correlated clinically, and after fur-
ther discussion with the radiology team about the findings on 
the MRI, the diagnosis of cavernous transformation of the 
portal vein (CTPV) was made. Gastrointestinal consultants 
requested for magnetic resonance venography (MRV) of the 
area, however, radiology concluded that further workup was 
unnecessary since the diagnosis was already made with the 
CT scan. 
Paracentesis was performed and the ascetic fluid was un-
remarkable for infection or malignancy.  The second hepatic 
panel showed an improvement with the results of total pro-
tein: 5.7 g/dL, albumin: 2.2 g/dL, total bilirubin: 11.1 mg/dL, 
direct bilirubin: 9.0 mg/L, GGTP: 137 U/L, LD: 211 U/L, 
AST: 84 U/L, ALT: 25 U/L. The biopsy of the mass near 
the antrum of the stomach and duodenum was unremark-
able. The level of CA-125 marker (54.6 U/mL; normal: < 
34.9 U/mL) was slightly elevated but it was minimal to have 
any significance. Alpha-fetoprotein level was within normal 
limits. The hepatic viral panel reported negative HBsAg and 
HBsAb with positive HbcAb and anti-HCV exhibiting anti-
HCV genotype 1b.
Over the course of his hospital stay, his leukocytosis 
trended down and the electrolytes were corrected to normal 
range. His symptoms of diarrhea subsided and his appetite 
returned to normal. Patient remained stable, and on the 15th 
day of his admission, he was transferred to a subacute facil-
ity to start a rehabilitation process.
Discussion
  
Cavernous transformation of the portal vein (CTPV) is a rare 
disease in adults. The development and dilatation of multiple 
small vessels in and around the recanalizing main portal vein 
leads to long-standing portal vein thrombosis (PVT) [2, 3]. 
Most cases present with signs and symptoms of acute upper 
gastrointestinal tract bleeding [5], which was not seen in our 
patient’s presentation. It usually occurs in healthy livers with 
chronic non-cirrhotic and non-tumoral PVT. 
There are several compensatory mechanisms occur 
when a healthy liver loses about two thirds of its blood sup-
ply. First, in the acute stage of PVT, hepatic artery dilates to 
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stabilize the liver by going through an ‘arterial rescue”. Sec-
ond, within a few days, there would be a rapid development 
and dilatation of collateral vessels in and around the intrahe-
patic and extrahepatic biliary tracts, and around gallbladder 
to bypass the obstruction. This “venous rescue” continues in 
its process and organizes into a cavernous transformation in 
around 3 - 5 weeks. These compensatory mechanisms can 
have harmful effects on intestinal circulation.
There is a wide range of presentations in CTPV. Most 
patients are asymptomatic at presentation. The clinical pre-
sentation of CTPV can range from normal biochemical and 
physical findings to cholestasis and splenomegaly with ab-
normal hepatic function [4]. In advanced stages, there may 
be a decrease in liver function due to gradual loss of hepatic 
mass. In 80% of patients with CVPT, strictures or displace-
ments in biliary ducts and main bile ducts are seen due to the 
changes of collateral vessels which are located near biliary 
tracts and gallbladder. This may appear similar to cholan-
giocellular cancer in Endoscopic Retrograde Cholangiopan-
creatography (ERCP) and therefore, is called “Pseudochol-
angiocarcinoma sign” (PSCS) [4].
The initial diagnosis of CTPV is seldom made in adults 
due to various etiologies and clinical presentations. Our pa-
tient was diagnosed with CTPV early in his stage when pre-
sented with obstructive jaundice, but diagnosis at this stage 
is rarely made. In addition, mildly increased serum alkaline 
phosphatase and direct reacting bilirubin levels with an el-
evation of related enzymes are the result of the compression 
of biliary tracts by the venous collaterals that run along the 
extrahepatic biliary tree [6]. All these features were exhib-
ited by our patient.
The diagnosis of CTPV is confirmed by abdominal ul-
trasonography, color Doppler ultrasonography, CT angiogra-
phy [2], and MRI [7]. The etiology of CTPV in our patient 
could not be determined. However, his past history of gall-
stone and alcoholic pancreatitis can explain the cause of his 
long-standing portal hypertension. In 1980, there was a case 
reported in Germany of a patient who had a partial obstruc-
tion of bile flow after posttraumatic thrombosis of the portal 
vein.  In this report, the stenosis was caused by varicosis 
of mural veins consistent with CTPV, a very rare cause of 
cholestasis [8]. This presentation is very similar to our pa-
tient, although there was no history of trauma reported by the 
patient. However, there is a history of an exploratory lapa-
rotomy made nine years before this admission; hence any 
indications or previous history remains a mystery. In further 
questioning the patient, he recalled that one of the physicians 
had mentioned pancreatitis, but no related history could have 
been obtained from the patient or his family. 
It has been demonstrated that the etiology of CTPV de-
termines the outcome, since the management differs with 
different causes [1]. For our patient, chronic liver disease 
would be the most logical etiology, but since his history is 
highly inaccurate, other conditions cannot be excluded.  
CTPV is an incurable disease with limited treatment 
options. Living-related liver transplantation is an effective 
procedure in treating CTPV. This procedure is very difficult 
in terms of reconstructing the portal vein [9], and it has only 
been studied in children and in severe portal hypertension, 
which our 58-year patient did not have. For the symptomatic 
biliary obstruction caused by CTPV, there is no consensus to 
an optimal treatment [10, 11]. Endoscopic management of 
biliary stricture seems to be effective and safe, but such an 
option was not offered to our patient, since his bilirubin level 
trended down and he appeared to be a poor candidate to any 
invasive procedures.
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